In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.
about
Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive DeclineMice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.Characterization of cerebral glutamine uptake from blood in the mouse brain: implications for metabolic modeling of 13C NMR dataMagnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?Neurometabolic profiles of the substantia nigra and striatum of MPTP-intoxicated common marmosets: An in vivo proton MRS study at 9.4 T.Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease.Progressive brain metabolic changes under deep brain stimulation of subthalamic nucleus in parkinsonian rats.Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.Differential effects of ethanol on regional glutamatergic and GABAergic neurotransmitter pathways in mouse brain.Molecular imaging and its applications: visualization beyond imagination.Energetics of Excitatory and Inhibitory Neurotransmission in Aluminum Chloride Model of Alzheimer's Disease: Reversal of Behavioral and Metabolic Deficits by Rasa Sindoor.Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component.Effects of electroacupuncture on metabolic changes in motor cortex and striatum of 6-hydroxydopamine-induced Parkinsonian rats.Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson's disease.
P2860
Q26741139-EE6797EE-1038-4485-8A09-663FD03EA981Q30438217-4792BA59-D694-4AFA-8A13-76DFA35DFB22Q30839491-5D0A0907-1AF7-40F0-A1DC-850F6BEC4B66Q30858994-3F2B772E-596E-4AB6-96B2-87467BC01A61Q38532562-E3F790F5-311A-441D-AAF7-75844B6606F3Q39060890-97BA6017-3B41-4A78-93EA-1773C0A63EE6Q40313187-9A2CA09B-983E-4510-8C84-43229E3A791AQ40462891-EEF844F1-0EB4-42C2-926E-F0A06A1B4792Q41657488-95779F8F-9D61-4DBF-AB07-F31B21AA1102Q42716494-61A25259-A421-401B-AD6F-7A568C5FC79DQ45343415-5E536E44-9F95-4AEB-9079-D994E8A8D2A5Q46782965-C64325B4-6B55-40C6-BFC3-2D7E6B0CBB26Q47167624-0FB5101B-A49D-40F0-AF24-9C4037AE35DEQ47998495-0DD42CB5-9C3F-45C2-8C45-1F5474AC220BQ48029943-11D93477-40C0-44C7-9379-B6AE07E14759Q48357495-E083CF9B-125D-4AFA-8244-9197EA29D0E4Q50025519-3A749D4E-6435-4980-9182-9F9218AECE4C
P2860
In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@en
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@nl
type
label
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@en
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@nl
prefLabel
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@en
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@nl
P2093
P2860
P356
P1476
In vivo NMR studies of regiona ...... with acute levodopa treatment.
@en
P2093
Anant B Patel
Anup N Chugani
Komanduri S Varadarajan
Puneet Bagga
P2860
P304
P356
10.1111/JNC.12407
P407
P577
2013-09-16T00:00:00Z